carvedilol has been researched along with Acute Hypercapnic Respiratory Failure in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Vasanthakumar, N | 1 |
CorrĂ , U | 1 |
Mezzani, A | 1 |
Giordano, A | 1 |
Bosimini, E | 1 |
Giannuzzi, P | 1 |
2 other studies available for carvedilol and Acute Hypercapnic Respiratory Failure
Article | Year |
---|---|
Beta-Adrenergic Blockers as a Potential Treatment for COVID-19 Patients.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme 2; Betacoronavirus; Carvedilol; Coronavir | 2020 |
Exercise haemodynamic variables rather than ventilatory efficiency indexes contribute to risk assessment in chronic heart failure patients treated with carvedilol.
Topics: Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Chronic Disease; Exercise; Female; Heart Failur | 2009 |